AB&B BIOTECH
Ab&B Biotech focuses on the research and development of innovative human vaccines and multivalent vaccines.
AB&B BIOTECH
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2015-01-01
Address:
Taizhou, Jiangsu, China
Country:
China
Website Url:
http://www.abbbio.com
Status:
Active
Contact:
0523-82205899
Email Addresses:
[email protected]
Total Funding:
92.73 M USD
Investors List
Qiandao Fund
Qiandao Fund investment in Series C - Ab&B Biotech
Sanhua Hongdao Investment
Sanhua Hongdao Investment investment in Series C - Ab&B Biotech
CS Capital
CS Capital investment in Series C - Ab&B Biotech
Puxin Capital
Puxin Capital investment in Series C - Ab&B Biotech
Green Pine Capital Partners
Green Pine Capital Partners investment in Series C - Ab&B Biotech
Official Site Inspections
http://www.abbbio.com
- Host name: 123.59.154.172
- IP address: 123.59.154.172
- Location: Beijing China
- Latitude: 39.9288
- Longitude: 116.3889
- Timezone: Asia/Shanghai
More informations about "Ab&B Biotech"
江苏中慧元通生物科技股份有限公司-新型疫苗,疫苗,新 …
江苏中慧元通生物科技股份有限公司在江苏省泰州市中国医药城注册成立，注册资本3.6亿元人民币，下属全资子公司——易慧生物技术（上海）有限公司成立于2020年，位于上海市浦东新区张江高科技园区，公司致力于人用创新型疫苗 …See details»
Ab&B Biotech - Crunchbase Company Profile & Funding
Organization. Ab&B Biotech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
Ab&b Bio-Tech - PitchBook
Mar 1, 2021 Ab&b Bio-Tech General Information Description. Developer of human vaccines and multivalent vaccines. The company completed its registration of quadrivalent influenza virus …See details»
Ab&B Bio-Tech Co., Ltd. - Drug pipelines, Patents, Clinical
Explore Ab&B Bio-Tech Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 13 clinical trials, 2 news, Disease Domain:Infectious Diseases, Neoplasms, Technology …See details»
Ab&B Bio-Tech Co., Ltd. - synapse.zhihuiya.com
3 days ago 了解Ab&B Bio-Tech Co., Ltd. (江苏中慧元通生物科技股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的13项临床试验, 53篇新闻，疾病领域:感染，肿瘤，技术平台:预防性疫苗，重组亚单位疫苗，生物类似药，多 …See details»
Product Center - Ab&B Bio
Product Center-Tetravalent influenza virus subunit vaccine (adult type)，child type，Ab&B Bio-Tech CO.,LTD.JSAb&B Bio-Tech CO.,LTD.JS was incorporated in China Medical City, …See details»
AB&B BIO-TECH - PharmaSource
AB&B BIO-TECH is a professional company dedicated to the research, development, production, and sales of human vaccines. With registered capital of 125 million RMB, the company …See details»
公司介绍_1-江苏中慧元通生物科技股份有限公司
江苏中慧元通生物科技股份有限公司在江苏省泰州市中国医药城注册成立，注册资本3.6亿元人民币，下属全资子公司——易慧生物技术（上海）有限公司成立于2020年，位于上海市浦东新区 …See details»
About AbbVie - Our Company | AbbVie
Signed and dated letter of request on your organization’s letterhead. Detailed budget breakdown. Contains the objectives and agenda. Number of events is clearly indicated. Article of …See details»
About Us_Tetravalent influenza virus subunit vaccine (adult
About Us-Tetravalent influenza virus subunit vaccine (adult type)，child type，Ab&B Bio-Tech CO.,LTD.JSAb&B Bio-Tech CO.,LTD.JS was incorporated in China Medical City, Taizhou City, …See details»
Ab&B Bio - Tetravalent influenza virus subunit vaccine (adult type ...
Dec 30, 2024 This strain is made by inoculating chicken embryos with type A and type B influenza virus strains recommended by the World Health Organization (WHO), after …See details»
About ABB - ABB Group
ABB is a global technology leader in electrification and automation. We see our purpose as being to enable a more sustainable and resource-efficient future. By connecting our engineering and …See details»
公司介绍-江苏中慧元通生物科技股份有限公司 - Ab&B Bio
江苏中慧元通生物科技股份有限公司在江苏省泰州市中国医药城注册成立，注册资本3.6亿元人民币，下属全资子公司——易慧生物技术（上海）有限公司成立于2020年，位于上海市浦东新区 …See details»
Member Registration for 2025 AABB Annual Meeting to Open June 4
3 days ago AABB (Association for the Advancement of Blood & Biotherapies) is an international, not-for-profit organization representing individuals and institutions involved in the fields of …See details»
中慧生物-动脉网 - vbdata.cn
Oct 28, 2015 江苏中慧元通生物科技股份有限公司注册资金3.6亿元人民币，建筑面积约170亩，其中一号生产园区项目投资10亿元人民币，二号生产园区项目投资20亿元人民币，三号生 …See details»
Product Center - Ab&B Bio
Currently, Phase III clinical trial has been completed and NDA production approval is pending. This product covers four influenza virus strains recommended by the World Health …See details»
Our Company - AbbVie
Signed and dated letter of request on your organization’s letterhead. Detailed budget breakdown; Article of Incorporation (or any legal document attesting of your entity’s legal status) The …See details»
News_News_Tetravalent influenza virus subunit vaccine (adult type ...
Recently, Ab&B Bio-Tech Co.,Ltd（Ab&B Bio）has received acceptance from the Drug Evaluation Center (CDE) of the China National Medical Products Administration for its …See details»
流感病毒亚单位疫苗（佐剂）IND申请获批 - abbbio.com
Oct 30, 2024 近日，江苏中慧元通生物科技股份有限公司（以下简称“中慧生物”）与子公司易慧生物技术（上海）有限公司（以下简称“易慧生物”）联合申报的一类新药“流感病毒亚单位疫苗（ …See details»
中慧元通-江苏中慧元通生物科技股份有限公司-企业详情-InvestGO …
查看医药魔方InvestGO®数据库中慧元通的公司信息。中慧元通（江苏中慧元通生物科技股份有限公司），公司简介：江苏中慧元通生物科技有限公司注册资金1.73亿元，一期项目总投资5亿 …See details»